The LRG keeps popping up in the science community. Recently, the National Institutes of Health (NIH) as part of the Consortium for Pediatric & GIST Research (of which, LRG is a part) submitted a poster [...]
GIST supporters showed their love for Texas marathoner Kate Poss. Keep reading for more on this inspirational story.
Here is a clinical trials update from December 2009 written by Jim Hughes United States RAD001 in combination with CP- 751,871 in patients with advanced sarcomas and other malignant neoplasms (NCT00927966) An mTOR inhibitor (RAD001) and [...]
An interesting Phase 2 REGISTER study is ongoing and actively recruiting at 15 sites in Australia. Two sites in New Zealand and two sites in South Korea are also planned.
Neva Hatten Hageman, passed away Wednesday (08/12/09) at The Ambassador in Nebraska City. She was born to George and Ruth (Kempf) Calkins, at home on the family farm, Northwest of McCook, in Hayes County. Those [...]
The fact is GIST is a rare disease and as a result researchers simply do not have enough GIST tissue samples to do the research needed to find a cure. “Too many people are still [...]
This poster reported the latest data from the GIST ReGISTry, an online database of GIST patient statistics maintained by a group of American and Canadian GIST specialists and supported by Novartis Pharmaceuticals.
Four GIST patients have entered this Phase 1 trial of PI3K inhibitor SF1126.
Innovative project will allow GIST researchers worldwide to access GIST tissue linked to patient-provided clinical histories. For more information on the GIST Tissue bank read the official press release.
LRG members share their experiences with elevated liver enzymes which are a rare side effect of Gleevec and can occur in CML and GIST patients.
